Incidence of HPV-positive head and neck cancer up in the U.S.

(HealthDay)—The rate of head and neck cancers has risen since the 1970s, and most are linked to human papillomavirus (HPV), according to a study recently published in Cancer Epidemiology, Biomarkers & Prevention.

Brandon A. Mahal, M.D., from the Dana-Farber Cancer Institute and Brigham and Women’s Cancer Center in Boston, and colleagues assessed data from 12,017 patients with squamous cell carcinoma of the head and neck in the Surveillance, Epidemiology, and End Results (SEER) HPV Status Database. Specifically, the authors reviewed data on patients who were diagnosed between 2013 to 2014 with oropharyngeal cancers and cancers of the hypopharynx, nasopharynx, and ‘other pharynx’ subsites. Cancer of the oral cavity and larynx were not included in the database.

The researchers found that during the study period, the incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons (95 percent confidence interval [CI], 4.51 to 4.73), compared with 1.82 for HPV-negative cancers (95 percent CI, 1.32 to 1.44). Having HPV-positive cancer was linked to lower cancer-specific mortality than HPV-negative cancer for oropharyngeal cancer (adjusted hazard ratio, 0.40; 95 percent CI, 0.30 to 0.53; P < 0.001) but not for the other subsites (adjusted hazard ratio, 1.08; 95 percent CI, 0.60 to 1.93; P = 0.81). Patients who were white and male had the highest rates of HPV-positive cancers, at 5.47 (95 percent CI, 5.33 to 5.61) and 8.00 (95 percent CI, 7.78 to 8.20) per 100,000 persons, respectively, and patients aged 60 to 64 years had the highest rates by age (peak rate of 27.23; 95 percent CI, 25.55 to 28.91).

Source: Read Full Article